top of page
Companies in the News
Gritstone Oncology Announces Data on Novel Shared Tumor-Specific Neoantigens Identified by its EDGE
EMERYVILLE, Calif., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company...
Nov 5, 2019
Oncology Start-Up Nuvation Bio Closes $275 Million Series A Financing Led by Omega Funds
Biotechnology Veteran David Hung, M.D. Launches Stealth Start-Up Focusing on the Foremost Unmet Needs in Oncology Nuvation Bio's...
Oct 28, 2019
GSK and Lyell Immunopharma join forces to develop the next generation of cancer cell therapies
Collaboration will combine Lyell’s technologies with GSK’s pipeline of cell therapies and manufacturing capability Issued: London and San...
Oct 8, 2019
FDA Grants EBR Systems Breakthrough Device Designation Status for the WiSE Cardiac Resynchronization
SUNNYVALE, Calif.--(BUSINESS WIRE)--EBR Systems, Inc., developer of the world’s only wireless cardiac pacing system for heart failure,...
Sep 10, 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Pr
Lead gene therapy candidate significantly reduced seizures and reversed early mortality in preclinical model of Dravet Syndrome Company...
Jun 26, 2019
BlackThorn Therapeutics Closes $76 Million Series B to Advance Targeted Therapeutics for Mental Heal
Company Also Expands Board of Directors and Executive Management Team with Key Appointments San Francisco – June 13, 2019 – BlackThorn...
Jun 13, 2019
Indigo launches The Terraton Initiative™ to remove one trillion tons of carbon dioxide from the atmo
At record levels of 415 parts per million (ppm), the Earth’s atmosphere contains one trillion tons (one teraton) more carbon dioxide...
Jun 12, 2019


A four-year-old start-up called Indigo Ag is the No. 1 company on the 2019 CNBC Disruptor 50 list
This Boston-based agricultural technology start-up is creating seed treatments that optimize the health of a plant in order to increase...
May 15, 2019
Vividion Secures $82 Million to Advance Its Lead Programs into the Clinic
Vividion Therapeutics snagged $82 million in an oversubscribed Series B funding round to bolster its cash holdings that will be used to...
Apr 30, 2019
bottom of page